Back to news & Events

Recipharm acquisition strengthens GenIbet’s expertise and global projection

The transaction allows Recipharm to benefit from GenIbet's know-how in the biopharmaceutical sector. GenIbet strengthens its technical capabilities, adds global recognition to its activity and helps to contribute to the quality of the research carried out in Portugal.

Recipharm, a global Contract Development and Manufacturing Organization, announced recently that it now owns 100% of GenIbet’s capital. This acquisition marks Recipharm’s entrance into the biopharmaceuticals market, benefiting from GenIbet’s path of innovation in this area. In turn, GenIbet can now profit from a more robust technological and industrial structure and from the parent company’s global reach.

With this operation, Portugal can also assume a more prominent role in the biotechnology sector, namely in terms of foreign investment, research, qualified employment and linkage to universities.

“We’ve enjoyed a great deal of success at GenIbet, and now is a fantastic time to be joining with Recipharm to share our expertise and broad service offer”, states Raquel Fortunato, the company CEO, in a news release issued in the company’s Linkedin page.

 

 

For his part, Mark Funk, Recipharm’s CEO, notes that “GenIbet is a leading player in this area and so we are proud to bring it into the Recipharm universe. We look forward to working closely together, building links with all of Recipharm in order to make this business a great success.”

 

 


GenIbet – a spin off company from iBET, the largest private Biotechnology Research Organization in Portugal, was the first biopharmaceutical company on the Iberian Peninsula with a GMP (Good Manufacturing Practices) certification, granted in 2009. Its 1st project was in the development and production of a typhoid fever vaccine, introduced by GVGH – a not-for-profit organization from GSK – in the Indian market in 2020. More recently, it has also played a crucial role in the development of mRNA technology, partnering with Moderna to take their very first mRNA vaccine in the clinic at the end of 2015.

 



Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. It has roughly 9000 employees spread across its headquarters in Stockholm (Sweden) and facilities in France, Germany, India, Israel, Italy, Portugal, Spain, United Kingdom and United States.

Until now, GenIbet’s capital was owned by iBet (49,66%), Medinfar (25,30%), Nutrinveste (12,88%) and Pentafar (11,15%).
Definições de Cookies

Genibet may use cookies to memorise the data you use when logging to Genibet website, gather statistics to optimise the functionality of the website and to carry out marketing campaigns based on your interests.

They allow you to browse the website and use its applications as well as to access secure areas of the website. Without these cookies, the services you have requested cannot be provided.
These cookies are necessary to allow the main functionality of the website and they are activated automatically when you enter this website. They store user preferences for site usage so that you do not need to reconfigure the site each time you visit it.
These cookies direct advertising according to the interests of each user so as to direct advertising campaigns, taking into account the tastes of users, and they also limit the number of times you see the ad, helping to measure the effectiveness of advertising and the success of the website organisation.

Required Cookies The cookies allow to customize the commercial offers that are presented to you, considering your interests. They can be our own or third party cookies. Please, be advised that, even if you do not accept these cookies, you will receive commercial offers, but do not match your preferences.

Functional Cookies The cookies offer you a more complete and personalised experience, allowing to safe preferences, showing you relevant content to your liking and send you alerts you have requested.

Advertising Cookies These cookies offer the possibility to connect to social media and share content from our website.